跳至主要内容
临床试验/NCT01291082
NCT01291082Unknown不适用

Whole-body Magnetische Resonantie Voor Het Opsporen Van Bot- en Weke Delenmetastasen Bij patiënten Met Een Borstcarcinoom (MetaMaRBo)

Universitaire Ziekenhuizen KU Leuven1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Validation of whole body diffusion weighted MRI in breastcancer patients

研究概览

简要总结

Prospective MR-imaging study : role of magnetic resonance (MR) and Diffusion weighted imaging (DWI) MR in staging and therapy assessment in breast cancer patients with bone metastases.

详细描述

About 50 patients with a proven breast cancer and bone metastases will be included.

First step : staging

  • nuclear bone scan
  • Positron Emission Tomography (PET/CT)
  • MR (whole body short tau inversion recovery (STIR)-sequence and T1-sequence and Diffusion weighted imaging (DWI),no contrast administration

Aim :

  • Validation of whole body diffusion weighted imaging in detection of bone metastases and visceral metastases, comparing to Bone scan en PET/CT results.
  • To calculate cut-off values for DWI for bone and visceral metastases.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with a proven breast cancer (by biopsy or imaging)
  • Bone metastases proven by MR, PET-CT or Bone. Patients with visceral metastases can be included if bone metastases are also present.
  • Patient with an informed consent.

排除标准

  • Patients with a single bone metastasis treated by Radiotherapy will be excluded.
  • Patients with contra-indication for MRI: pacemaker, cochlear implant, non MR compatible devices (Baclofenpump).
  • Claustrophobia
  • Patient in a bad general condition.

结局指标

主要结局

Validation of whole body diffusion weighted MRI in breastcancer patients

时间窗: 6 months

whole body MRI will be correlated to the nucleair bone scan and PET-CT

次要结局

  • Whole body MRI with diffusion weighted imaging is a reliable imaging tool for therapy assessment(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steven Pans

Medical Doctor radiologist

Universitaire Ziekenhuizen KU Leuven

研究点 (1)

Loading locations...

相似试验

Whole-body MR in Staging Bone and Soft Tissue... | 临床试验